NBTY reaping market's bounty with 82% first quarter gain in stock price -- Index.
This article was originally published in The Tan Sheet
Executive Summary
NBTY REAPING MARKET's BOUNTY WITH 82% FIRST QUARTER GAIN in stock price as a growing retail presence enhanced NBTY's appeal in a generally strong market for dietary supplement stocks. A better-than-expected NBTY first quarter -- sales rose 131% and earnings surged ahead 46% -- impressed investors with the strength of the company's core business and the success of its ventures into retail. With a 27-3/8 advance to 60-3/4 at the end of the quarter, NBTY built on a 75% appreciation in stock price for all of 1997.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning